About: http://webisa.webdatacommons.org/290394138

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	Repaglinide was compared to other insulin secretagogues in 1-year controlled trials to demonstrate comparability of efficacy and safety.
http://www.w3.org/ns/prov#wasQuotedFrom	reverse-diabetes-today.net